Abstract
Conclusion and Summary
There was an apparent, brief prolongation of the mean skin homograft survival in 241 rats which were given 6-MP. However, neither long term administration nor high doses of this drug consistently prolonged survival time. A few of the treated animals in the higher dosage groups had unusually long graft survivals which accounted for the over-all increase of mean graft survival. Most of the animals in all groups sloughed off their grafts at or near the expected time.
Get full access to this article
View all access options for this article.